- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
AMO names new president, Randy Meier
Richard "Randy" A. Meier has been named president of Advanced Medical Optics Inc. (AMO), effective Nov. 19. He retains his existing chief operating officer (COO) title and responsibilities, which include leadership of the company's eye care and cataract/implant businesses, global customer services, and manufacturing operations.
Santa Ana, CA- Richard "Randy" A. Meier has been named president of Advanced Medical Optics Inc. (AMO), effective Nov. 19. He retains his existing chief operating officer (COO) title and responsibilities, which include leadership of the company's eye care and cataract/implant businesses, global customer services, and manufacturing operations.
James V. Mazzo, previous holder of the title of president, remains the company's chairman and chief executive officer.
"Randy has assumed increasingly broad leadership roles since our spin-off in 2002 and, over that time, has played an integral role in the growth and development of our company," said Mazzo. "I am confident in his ability to serve as president, continuing to work closely with me and the AMO leadership team to execute our strategy and deliver on our operational and financial goals."
